May 28, 2020

FORMULATION FORUM: New Drug Candidates Formulation Research Strategy

Formulation scientists can provide early stage formulations that manage risks, enable clear inferences from the results of in vivo studies, and allow differentiation between multiple leads, despite intrinsic limitations. In this Formulation Forum, Ascendia CEO Jim Huang, PhD explains what those limitations are and how to overcome them.

Drug Development & Delivery March 2019 column

As noted by Dr. Huang in the Forum, an ideal drug development approach involves a thorough understanding of the physical-chemical and biopharmaceutical properties in relationship to drug dissolution, absorption, and the disposition process in the body while taking advantage of advanced formulation technologies. Learn more by reading the column published by Drug Development & Delivery, a leading media outlet serving the pharmaceutical market.

  Back to articles

Want to learn more about
Ascendia's expertise?

Get up-to-date information

Stay in touch >